Surgical management of sinonasal hemangiopericytomas: A case series

Abstract

Surgery for sinonasal hemangiopericytomas can be challenging; both endoscopic and open approaches may be used to treat these highly vascular tumors.

Endoscopic transnasal management of sinonasal malignancies - our initial experience.

“…There are only a few studies reporting long-term results of surgical treatment of sinonasal hemangiopericytoma from a single institution in the literature. All of them present a limited number of patients [16, 17]. Most of the authors consider these tumors clinically and biologically as benign lesions.…”

“…Most of the authors consider these tumors clinically and biologically as benign lesions. Local recurrences were reported up to 13 years after surgical resection [16]. Metastasizing and locally aggressive HPC of head and neck was described in the literature [18]; however, in a study summarizing results of treatment of 104 sinonasal hemangiopericytomas from different institutions from a 25-year period, there was no single case of a metastasizing tumor [19].…”

Characteristics and prognosis of glomangiopericytomas: A systematic review

“…After full‐text assessment, 139 articles were also excluded: articles containing no histologic findings (n = 20), unclear histology (n = 10), duplicate cases (n = 3), cases not arising in the sinonasal tract (n = 21), other sinonasal tumors, such as solitary fibrous tumor (n = 39), glomus tumor (n = 27), myopericytoma (n = 3), fibroma (n = 1), papilloma (n = 1), and lymphoma (n = 1), and reviews without information about individual cases (n = 13). Finally, 80 articles containing glomangiopericytoma of the sinonasal tract (337 cases) were identified as eligible for this study . Most articles (75/80; 94%) were published in English, except for 5 articles written in Korean …”

Hemangiopericitoma nasosinusal: reporte de caso

“…La embolización prequirúrgica disminuye el riesgo de sangrado intraoperatorio y disminuye el tamaño del tumor. Sin embargo no está clara su indicación y no hay estudios comparativos específicos para esta entidad (8). En el estudio realizado por Serrano et al (11), los 5 pacientes fueron llevados a embolización preoperatoria, mientras Bignami et al (12) practicaron embolización sólo en aquellos pacientes que parecen tener vasos nutricios claramente visibles desde la arteria maxilar.…”

“…En las últimas dos décadas se han publicado menos de 250 casos, y dado que difiere en sus características con los HPCs del resto del cuerpo, es ampliamente aceptado que representa una entidad distinta (3). Puede ser designado como glomangiopericitoma (6) según la clasificación de Organización Mundial de la Salud de tumores de cabeza y cuello del 2005, debido a su similitud con los tumores glómicos (7); por otro lado algunos lo consideran un sarcoma de bajo grado (8). Fue llamado por Compagno y Hyans (9) como "hemangiopericitoma like intranasal tumor" en 1976, siendo los primeros en describir detalladamente sus características histopatológicas (10).…”